Insmed (INSM) Misses Q3 EPS by 41c, provide guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $117.32 -3.48%
Revenue Growth %: +253.0%
Financial Fact:
Investment income: 138K
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +253.0%
Financial Fact:
Investment income: 138K
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($1.75), $0.41 worse than the analyst estimate of ($1.34). Revenue for the quarter came in at $142 million versus the consensus estimate of $114.87 million.
GUIDANCE:
Insmed sees FY2025 revenue of $420-430 million, versus the consensus of $471.3 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Scott Bessent will not be going to be super intelligence (SI) czar
- Iran's President says Tehran agrees on need to return to Islamabad understanding, honor commitments
- Goldman Sachs Assumes Insmed (INSM) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
